IntelliPharmaCeutics International (IntelliPharmaCeutics International) Short-Term Capital Lease Obligation : $0.04 Mil (As of Aug. 2023)

View and export this data going back to 1996. Start your Free Trial

What is IntelliPharmaCeutics International Short-Term Capital Lease Obligation?

IntelliPharmaCeutics International's Short-Term Capital Lease Obligation for the quarter that ended in Aug. 2023 was $0.04 Mil.

IntelliPharmaCeutics International's quarterly Short-Term Capital Lease Obligation declined from Feb. 2023 ($0.14 Mil) to May. 2023 ($0.08 Mil) and declined from May. 2023 ($0.08 Mil) to Aug. 2023 ($0.04 Mil).

IntelliPharmaCeutics International's annual Short-Term Capital Lease Obligation declined from Nov. 2020 ($0.16 Mil) to Nov. 2021 ($0.00 Mil) but then increased from Nov. 2021 ($0.00 Mil) to Nov. 2022 ($0.17 Mil).

IntelliPharmaCeutics International Short-Term Capital Lease Obligation Historical Data

The historical data trend for IntelliPharmaCeutics International's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International Short-Term Capital Lease Obligation Chart

IntelliPharmaCeutics International Annual Data

Trend

Nov13

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.16

0.17

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.04	0.17	0.14	0.08	0.04

IntelliPharmaCeutics International Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

IntelliPharmaCeutics International Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

IntelliPharmaCeutics International (IntelliPharmaCeutics International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (OTCPK:IPCIF) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

I4AA:Germany IPCI:Canada

Address

30 Worcester Road, Toronto, ON, CAN, M9W 5X2

Website

https://www.intellipharmaceutics.com

IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.